A case of acromegaly with extensive coronary collateralization is reported. Growth hormone may have played a role in this neovascularization.
Get full access to this article
View all access options for this article.
References
1.
Schaper W.: The Collateral Circulation of the Heart. New York , American Elsevier Pub Co, 1971 , pp. 221-227.
2.
Meffert M., Liebow AA: Hormonal control of collateral circulation. Circ Res18:228-233, 1966.
3.
Lundbaek K., Jensen VA, Olsen TS, et al: Diabetes, diabetic angiopathy, and growth hormone. Lancet2:131-133, 1970.
4.
Aloia JF, Grover RW: Dermal changes in osteoporosis following prolonged treatment with human growth hormone. J Cut Path3:222-231, 1976.
5.
Ledet T.: Growth hormone stimulating the growth of arterial medial cells in vitro. Absence of effect of insulin. Diabetes25:1011-1017, 1976.
6.
McGuffin WLJr, Sherman BM, Roth J., et al: Acromegaly and cardiovascular disorders. A prospective study. Ann Intern Med81:11-18, 1974.
7.
Merimee TJ, Fineberg E., Hollander W.: Vascular disease in chronic HGH-deficient state. Diabetes22:813-819, 1973.
8.
Friedman F., Byers SO, Rosenman RH, et al: Effect of subacute administration of human growth hormone on various serum lipid and hormone levels of hypercholesterolemimic and normocholesterolemic subjects. Metabolism23:905-912, 1974.
9.
Aloia JF, Zanzi I., Cohn SH: Absence of an effect of chronic administration of growth hormone on serum lipids.
10.
Van Wyk JJ, Underwood LE: Relation between growth hormone and somatomedin. Ann Rev of Med26:427-441, 1975.
11.
Helfant RH, Vokonas PS, Gorlin R.: Functional importance of the human coronary collateral circulation . NEJM284:1277-1281, 1971 .
12.
Banka VS, Bodenheimer MM, Helfant RH: Determinants of reversible asynergy. Effect of pathologic Q waves, coronary collaterals, and anatomic location. Circ50:714-719, 1977.
13.
Levin DC: Pathways and functional significance of the coronary collateral circulation . Circ50:831-837, 1974.
